Actively Recruiting
An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy
Led by The University of Hong Kong · Updated on 2026-03-09
138
Participants Needed
2
Research Sites
143 weeks
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
Q
Queen Mary Hospital, Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer. The main question it aims to answer is: How effective is the Digi-Coach chatbot in reducing physical and psychological distress? Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer. Participants will have access to the Digi-Coach chatbot during radiotherapy in addition to usual care. The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot.
CONDITIONS
Official Title
An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 and above
- Able to read and speak Cantonese or Mandarin fluently
- Have a new, primary diagnosis of head and neck or laryngeal cancer
- Waiting to receive a full course of curative-intent, external beam radiotherapy with or without chemotherapy
- Have a Karnofsky performance score of 70 or higher
- Have distress scored 3 or above on the NCCN distress thermometer
You will not qualify if you...
- Insufficient command of Chinese
- Any factors preventing ability to give informed consent or comply with study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The University of Hong Kong
Hong Kong, Hong Kong, Hong Kong, 000000
Active, Not Recruiting
2
Queen Mary Hospital
Hong Kong, Hong Kong, Hong Kong
Actively Recruiting
Research Team
T
Tongyao Wang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here